Resveratrol as a Nutraceutical: Current Research and Future Perspectives

Ericwan desif, Department of Food Science, University of Massachusetts, Massachusetts, USA, Email: Ericde5798@gmail.com

Received: 03-Jul-2023, Manuscript No. EJMOAMS-23-107602; Editor assigned: 06-Jul-2023, Pre QC No. EJMOAMS-23-107602 (PQ); Reviewed: 20-Jul-2023, QC No. EJMOAMS-23-107602; Revised: 27-Jul-2023, Manuscript No. EJMOAMS-23-107602 (R); Published: 04-Aug-2023

About the Study

Resveratrol, a natural polyphenolic compound found in various plants, has gained significant attention as a potential nutraceutical due to its diverse biological ac- tivities and potential health benefits. Numerous studies have investigated the therapeutic potential of resvera- trol, suggesting its efficacy in a wide range of conditions such as cardiovascular diseases, cancer, neurodegenera- tive disorders, and metabolic disorders [1].

Mechanisms of action

Resveratrol exerts its biological effects through multiple mechanisms, making it a versatile compound for vari- ous health conditions. One of its key mechanisms is its ability to activate sirtuin proteins, particularly SIRT1, which plays a crucial role in cellular metabolism and aging. Resveratrol’s activation of SIRT1 leads to various downstream effects, including enhanced mitochondrial function, improved insulin sensitivity, and reduced in- flammation.

Furthermore, resveratrol demonstrates potent antiox- idant properties, protecting cells and tissues against oxidative stress-induced damage. It also exhibits an- ti-inflammatory effects by inhibiting the expression of pro-inflammatory cytokines and enzymes [2,5]. These anti-inflammatory properties contribute to its potential in preventing and managing chronic inflammatory dis- eases.

Clinical evidence

Research on resveratrol has provided promising results in both preclinical and clinical studies. In cardiovascular health, resveratrol has shown potential in reducing the risk of cardiovascular diseases, such as atherosclerosis, hypertension, and ischemic heart disease. It exerts car- dioprotective effects by improving endothelial function, reducing oxidative stress, inhibiting platelet aggrega- tion, and decreasing inflammation. However, further large-scale clinical trials are needed to establish its ther- apeutic efficacy and optimal dosages.

Resveratrol’s anti-cancer properties have also been ex- tensively studied. It exhibits various anticancer effects, including inhibition of tumor initiation, proliferation, and metastasis, as well as induction of apoptosis. Pre- clinical studies have shown promising results in differ- ent cancer types, such as breast, prostate, colon, and lung cancers [6]. However, more clinical studies are re- quired to evaluate its effectiveness and safety in human populations.

In neurodegenerative disorders, resveratrol shows po- tential as a neuroprotective agent. It exhibits anti-inflam- matory, antioxidant, and anti-amyloidogenic properties, which may help mitigate neuroinflammation, oxidative stress, and accumulation of amyloid-beta plaques seen in conditions like Alzheimer’s and Parkinson’s diseases. Clinical trials investigating resveratrol’s efficacy in neu- rodegenerative disorders are ongoing, with promising preliminary results [7].

Future perspectives

The growing body of research on resveratrol highlights its potential for future applications in various health conditions. However, several challenges need to be ad- dressed to maximize its therapeutic benefits. One of the key challenges is its low bioavailability, as resveratrol has poor solubility and undergoes rapid metabolism. Various strategies have been explored to improve its bioavailability, including the use of resveratrol ana- logs, nanoparticle formulations, and co-administration with absorption enhancers. Further advancements in delivery systems and dosage optimization are needed to enhance its efficacy [8]. Combination therapies in- volving resveratrol and other bioactive compounds or conventional drugs are another avenue of exploration. Synergistic effects have been observed when resveratrol is combined with other polyphenols, such as curcumin or quercetin, suggesting potential benefits in combina- tion therapy approaches. Additionally, investigating the potential interactions between resveratrol and conven- tional medications will be crucial to ensure safety and efficacy. Personalized medicine approaches may also play a significant role in optimizing resveratrol’s effects [9]. Genetic variations among individuals can influence resveratrol metabolism and response, and tailoring dosages based on genetic profiles may enhance its ef- ficacy. Furthermore, identifying biomarkers for patient stratification and monitoring treatment responses will aid in determining the appropriate population for res- veratrol-based interventions. Resveratrol holds great promise as a nutraceutical due to its diverse biological activities and potential health benefits. Current research indicates its efficacy in various conditions, including cardiovascular diseases, cancer, neurodegenerative disorders, and metabolic disorders. However, further research is needed to optimize its bioavailability, ex- plore combination therapies, personalize treatment approaches, and establish long-term safety. With contin- ued scientific investigation, resveratrol may emerge as a valuable tool in preventive and therapeutic interven- tions for improving human health [10].

References

1. ŞENER B, KILIÇ M, SHARI FIRAD J, SALAHI B, PRAKASHMISHRA A, NIGAM M, et al. Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines 2018; 6(3):91.
2. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002; 50(11):3337-3340.
3. Renaud SD, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339(8808):1523-1526.
4. Marques FZ, Markus MA, Morris BJ. Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 2009;41(11):2125-2128.
5. Malhotra A, Bath S, Elbarbry F. An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol. Oxid Med Cell Longev 2015; 2015.
6. Konyalioglu S, Armagan G, Yalcin A, Atalayin C, Dagci T. Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells. Neural Regen Res 2013; 8(6): 485.
7. Means JC, Gerdes BC, Koulen P. Distinct mechanisms underlying resveratrol-mediated protection from types of cellular stress in C6 glioma cells. Int J Mol Sci 2017;18(7):1521.
8. Malaguarnera L. Influence of resveratrol on the immune response. Nutrients 2019;11(5):946.
9. Zunino SJ, Hwang DH, Huang S, Storms DH. Resveratrol increases phagocytosis and lipopolysaccharide-induced interleukin-1β production, but decreases surface expression of Toll-like receptor 2 in THP-1 monocytes. Cytokine. 2018;102:141-144.
10. Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, et al. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev 2017;36:11-19.

Copyright: © 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution NonCommercial ShareAlike 4.0 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.